Symmetry will include Codman’s line of surgical instruments with in its current hospital direct business, Specialty Surgical Instrumentation (SSi).
After integrating all of the Codman’s instruments, Symmetry’s hospital direct general surgical instruments business will be re-named as Symmetry Surgical.
Symmetry Medical president and CEO Thomas Sullivan said Symmetry Surgical offers several strategic benefits with increased revenue diversification, enhanced gross margin, a strategic instruments procurement capability in Tuttlingen, Germany, and a strengthened intellectual property portfolio.
"This positions us well to continue growing our US market share in the hospital direct business, as well as building on the strong international presence established abroad by the brands acquired from Codman," Sullivan said.
